This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Mirobio Limited, Oxford University Innovation Ltd. Active years: 2022.
Company Filing History:
1 out of 1 
1 out of 483 
Years Active: 2022
Title: Richard John Cornall: Innovator in Antibody Technology
Introduction
Richard John Cornall is a notable inventor based in Oxford, GB. He has made significant contributions to the field of immunology, particularly through his work on antibodies. His innovative approach has led to advancements in the treatment of various diseases.
Latest Patents
Cornall holds a patent for BTLA antibodies. This invention relates generally to antibodies or antigen binding fragments that bind to human B and T lymphocyte attenuator (BTLA) and their uses. More specifically, the invention focuses on agonistic antibodies that bind human BTLA and modulate its activity. These antibodies have potential applications in treating inflammatory, autoimmune, and proliferative diseases and disorders.
Career Highlights
Throughout his career, Richard John Cornall has worked with prominent organizations such as Mirobio Limited and Oxford University Innovation Ltd. His work in these institutions has allowed him to further develop his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Christopher Douglas Paluch and Simon Paul Davis. Their collaborative efforts have enhanced the research and development of antibody technologies.
Conclusion
Richard John Cornall's contributions to antibody technology and his innovative spirit have made a significant impact in the field of immunology. His work continues to inspire advancements in the treatment of various diseases.